SCHEMBL13234462

SCHEMBL13234462

COc1ccc(CNC(=O)Nc2cc(C(C)(C)C)no2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
SMN1; SMN2 Q16637 1/20 0.54
RAF1 P04049 2/20 0.54
POLB P06746 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
NPC1 O15118 4/20 0.52
RAB9A P51151 4/20 0.52
MAPK14 Q16539 4/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
HTT P42858 1/20 0.51
MAPT P10636 1/20 0.49
EPHX2 P34913 1/20 0.48
NR1H4 Q96RI1 1/20 0.48
KDM4E B2RXH2 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
BRAF P15056 1/20 0.47
GSK3A P49840 1/20 0.47
GSK3B P49841 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3175321 0.87 RAF1 (0.73) ALDH1A1SMN1; SMN2RAF1MAPK14HTT
SCHEMBL13200803 0.83 KMT2A (0.61) ALDH1A1SMN1; SMN2RAF1L3MBTL1MAPK14
SCHEMBL13234433 0.83 RAF1 (0.74) ALDH1A1SMN1; SMN2RAF1POLBNPC1
SCHEMBL667912 0.80 RAF1 (0.70) ALDH1A1SMN1; SMN2RAF1POLBNPC1
SCHEMBL669077 0.80 RAF1 (0.81) ALDH1A1SMN1; SMN2RAF1POLBNPC1
SCHEMBL2944830 0.80 RAF1 (0.66) SMN1; SMN2RAF1POLBL3MBTL1NPC1
SCHEMBL15121199 0.77 ALDH1A1 (0.70) ALDH1A1RAF1MAPK14BRAF
SCHEMBL2943178 0.76 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2RAF1NPC1RAB9A
SCHEMBL11018656 0.75 ALDH1A1 (0.67) ALDH1A1RAF1MAPK14BRAF
SCHEMBL1465888 0.74 CNR2 (0.56) ALDH1A1RAF1MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173917-A1 UREA DERIVATIVES AS ABL MODULATORS AMBIT BIOSCIENCES CORPORATION 2010-07-08 US disclosed
US-20100173917-A1 UREA DERIVATIVES AS ABL MODULATORS AMBIT BIOSCIENCES CORPORATION 2010-07-08 US disclosed
US-7750160-B2 Isoxazolyl urea derivatives as kinase modulators AMBIT BIOSCIENCES CORPORATION (US) 2010-07-06 US disclosed
US-7750160-B2 Isoxazolyl urea derivatives as kinase modulators AMBIT BIOSCIENCES CORPORATION (US) 2010-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173917-A1 UREA DERIVATIVES AS ABL MODULATORS ABL1, ABL2, BCR ALDH1A1 620/4885SMN1; SMN2 3974/4885RAF1 372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.